ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    INTRAVENOUS LIDOCAINE AND NALBUPHINE IN PAIN MANAGEMENT FOR UPPER EXTREMITY FRACTURE- A CLINICAL TRIAL


    Dr. ADUSUMILLI BHAVANA SRI, Dr. Belli Yashaswi, Dr. Abhijith Kanti Dam, Dr. Birendra Kumar, Dr. Dharun Jims D A, Dr. Harihar Jadhav
    JCDR. 2024: 3889 -3916

    Abstract

    Background- Lidocaine is a relatively safe drug in the amide group, which acts as an analgesic, anti-hyperalgesia and anti-inflammatory agent in low doses and is affective in relieving neuralgia, burn and procedural pains. Nalbuphine is a newer opioid drug with antagonism at µ receptors and agonism at κ receptors, with no significant effects on delta receptors.

    Description

    .

    » PDF

    Volume & Issue

    Volume 15 Issue 6

    Keywords